Evan Foster Shalen

Title: The Innovations of Evan Foster Shalen

Introduction

Evan Foster Shalen is an accomplished inventor based in Mill Valley, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that modulate Fatty Acid Amide Hydrolase (FAAH). His work has the potential to impact the treatment of various disorders.

Latest Patents

Evan holds a patent for "Oxazole derivatives useful as modulators of FAAH." This invention focuses on specific Oxazole derivatives that serve as modulators of FAAH and as imaging agents. The patent also encompasses pharmaceutical formulations that include these compounds as active ingredients. These formulations are aimed at treating a range of disorders, including osteoarthritis, rheumatoid arthritis, diabetic neuropathy, postherpetic neuralgia, skeletomuscular pain, fibromyalgia, acute pain, migraine, sleep disorders, Alzheimer’s Disease, and Parkinson's Disease. He has 1 patent to his name.

Career Highlights

Evan is currently associated with Merck Sharp & Dohme Corporation, where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to improving patient outcomes through advanced therapeutic solutions.

Collaborations

Evan has collaborated with notable colleagues, including ZhiQiang Yang and Philippe G Nantermet. These partnerships have further enriched his research and development efforts.

Conclusion

Evan Foster Shalen's contributions to the field of pharmaceuticals through his innovative patents demonstrate his dedication to advancing medical science. His work has the potential to significantly improve the quality of life for individuals suffering from various health conditions.